Saptalis Pharms patents expiration
1. Likmez patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11541035 | SAPTALIS PHARMS | Oral formulations of metronidazole and methods of treating an infection using same |
Oct, 2039
(15 years from now) | |
Drugs and Companies using METRONIDAZOLE ingredient
Market Authorisation Date: 22 September, 2023
Treatment: NA
Dosage: SUSPENSION;ORAL
More Information on Dosage
LIKMEZ family patents
